JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling

被引：14
|
作者：
Ren, Yanlin [1 ,2 ,5 ]
Chen, Dongyin [3 ]
Zhai, Zurong [1 ,2 ]
Chen, Junjie [1 ,2 ]
Li, Aiping [1 ,2 ]
Liang, Yan [2 ,4 ]
Zhou, Jianwei [1 ,2 ]
机构：
[1] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Mol Cell Biol & Toxicol, Nanjing 211166, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatm, Nanjing 211166, Peoples R China
[3] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing 211166, Peoples R China
[4] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing 211166, Peoples R China
[5] Nantong Ctr Dis Control & Prevent, Nantong 226007, Peoples R China
来源：
CELL DEATH DISCOVERY | 2021年 / 7卷 / 01期
基金：
中国国家自然科学基金;
关键词：
CELL-PROLIFERATION; GASTRIC-CANCER; LUNG-CANCER; JWA; EXPRESSION; GROWTH; RESISTANCE; MIGRATION; INVASION; HER2;
D O I：
10.1038/s41420-021-00426-y
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The overexpression of HER2 is associated with a malignant proliferation of breast cancer. In this study, we developed a non-cytotoxic JWA gene activating compound 1 (JAC1) to inhibit the proliferation of HER2-positive breast cancer cells in vitro and in vivo experimental models. JAC1 increased the ubiquitination of HER2 at the K716 site through the E3 ubiquitin ligase SMURF1 which was due to the decreased expression of NEDD4, the E3 ubiquitin ligase of SMURF1. In conclusion, JAC1 suppresses the proliferation of HER2-positive breast cancer cells through the JWA triggered HER2 ubiquitination signaling. JAC1 may serve as a potential therapeutic agent for HER2-positive breast cancer.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
    Zhai, Zurong
    Ren, Yanlin
    Shu, Chuanjun
    Chen, Dongyin
    Liu, Xia
    Liang, Yan
    Li, Aiping
    Zhou, Jianwei
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [2] Estrogen suppresses breast cancer proliferation through GPER/p38 MAPK axis during hypoxia
    Sathya, S.
    Sudhagar, S.
    Lakshmi, B. S.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 417 (0C) : 200 - 210
  • [3] SMURF1 facilitates estrogen receptor. signaling in breast cancer cells
    Yang, Huijie
    Yu, Na
    Xu, Juntao
    Ding, Xiaosheng
    Deng, Wei
    Wu, Guojin
    Li, Xin
    Hou, Yingxiang
    Liu, Zhenhua
    Zhao, Yan
    Xue, Min
    Yu, Sifan
    Wang, Beibei
    Li, Xiumin
    Niu, Gang
    Wang, Hui
    Zhu, Jian
    Zhuang, Ting
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [4] Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis
    Wang, Xiu-Feng
    Zhou, Qian-Mei
    Lu, Yi-Yu
    Zhang, Hui
    Huang, Shuang
    Su, Shi-Bing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (05) : 577 - 587
  • [5] SAMHD1, positively regulated by KLF4, suppresses the proliferation of gastric cancer cells through MAPK p38 signaling pathway
    Chen, Zhangming
    Jiang, Zhe
    Meng, Lei
    Wang, Ye
    Lin, Minggui
    Wei, Zhijian
    Han, Wenxiu
    Ying, Songcheng
    Xu, Aman
    CELL CYCLE, 2022, 21 (19) : 2065 - 2078
  • [6] EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis
    Moore, Heather M.
    Gonzalez, Maria E.
    Toy, Kathy A.
    Cimino-Mathews, Ashley
    Argani, Pedram
    Kleer, Celina G.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (03) : 741 - 752
  • [7] P38 MAPK Contributes to Resistance and Invasiveness of HER2-Overexpressing Breast Cancer
    Donnelly, S. M.
    Paplomata, E.
    Peake, B. M.
    Sanabria, E.
    Chen, Z.
    Nahta, R.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (04) : 501 - 510
  • [8] LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway
    Xu, Peiyuan
    Cai, Fei
    Liu, Xiaofei
    Guo, Lele
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8480 - 8488
  • [9] GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ER? signaling
    Tang, Hai -Li
    Wang, Qi
    Lu, Jian-Guo
    Yang, Xiao-Jun
    Shi, Jiao-Jiao
    Wang, Sheng-Peng
    Cao, Chang-Qing
    Zhao, Hua-Dong
    NEOPLASMA, 2022, 69 (06) : 1386 - 1395
  • [10] USF2 inhibits the transcriptional activity of Smurf1 and Smurf2 to promote breast cancer tumorigenesis
    Tan, Yawen
    Chen, Yujiao
    Du, Mengge
    Peng, Zhiqiang
    Xie, Ping
    CELLULAR SIGNALLING, 2019, 53 : 49 - 58
12345